Corepharma Announces Completion of Fourth Treasury Stock Buyback Program

Release Date: July 14, 115 Statement Date: July 13, 115 Statement Time: 16:51 Company Code: 1786 Company Name: Corepharma Subject: Announcement of Execution Status upon Completion of the Fourth Share Buyback Program Applicable Clause: Item 35 Factual Date: July 13, 115

Details: 1. Original upper limit of total repurchase amount (NT$): 1,066,892,940 2. Original repurchase period: 05/15/115 ~ 07/13/115 3. Original number of shares to be repurchased (shares): 5,000,000 4. Original repurchase price range (NT$): 38.10 ~ 90.30 5. Actual repurchase period: 05/15/115 ~ 07/13/115 6. Number of shares actually repurchased (shares): 2,136,000 7. Total amount spent on repurchased shares (NT$): 123,012,298 8. Average repurchase price per share (NT$): 57.59 9. Cumulative number of own shares held (shares): 2,136,000 10. Percentage of cumulative own shares held to total issued shares (%): 2.85 11. Reason for incomplete execution: To balance market mechanisms and protect overall shareholder interests, the company monitored stock price movements and considered efficient capital utilization, thus not fully completing the repurchase. 12. Other matters to be disclosed: None